Adenovirus-mediated overexpression of Fas induces apoptosis of gliomas

Cancer Gene Therapy

Volumn 7, Issue 2, 2000, Pages 224-232

  Shinoura, Nobusada ^a,b   Ohashi, Makoto ^a   Yoshida, Yoko ^a   Kirino, Takaaki ^b,c   Asai, Akio ^b   Hashimoto, Mitsuhiro ^d   Hamada, Hirofumi ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Japan Science and Technology Agency   (Japan)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Adenovirus vector; Bcl X(L); Fas; Gene therapy; Glioma; Myelin basic protein

Indexed keywords

FAS ANTIGEN; MYELIN BASIC PROTEIN; PROTEIN BCL X; VIRUS VECTOR;

ADENOVIRUS; APOPTOSIS; ARTICLE; GENETIC TRANSDUCTION; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION;

ADENOVIRIDAE;

EID: 0034071499     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700110     Document Type: Article

References (43)

1. Bargou RC, Daniel PT, Mapara MY, et al. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-α expression in tumor cells correlates with resistance toward apoptosis. Int J Cancer. 1995;60:854-859.
2. Krajewski S, Blomqvist C, Franssila K, et al. Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 1995;55:4471-4478.
3. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991;66:233-243.
4. Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest. 1993;69:415-429.
5. Tachibana O, Nakazawa H, Lampe J, et al. Expression of Fas/APO-1 during progression of astrocytomas. Cancer Res. 1995;55:5528-5530.
6. Owen-Schaub LB, Radinsky R, Kruzel E, et al. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 1994;54:1580-1586.
7. Weller M, Malipiero U, Rensing-Ehl A, et al. Fas/APO-1 gene transfer for human malignant glioma. Cancer Res. 1995;55:2936-2944.
8. Shinoura N, Yoshida Y, Sadata A, et al. Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy. Hum Gene Ther. 1998;9:1983-1993.
9. Miyao Y, Shimizu K, Moriuchi S, et al. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression. J Neurosci Res. 1993;36:472-479.
10. Miyao Y, Shimizu K, Tamura M, et al. Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein is strongly active in human malignant glioma cells. Jpn J Cancer Res. 1997;88: 678-686.
11. Hashimoto M, Aruga J, Hosoya Y, et al. A neural cell-type-specific expression system using recombinant adenovirus vectors. Hum Gene Ther. 1998;7:149-158.
12. Yoshida Y, Hamada H. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. Biochem Biophys Res Commun. 1997;230:426-430.
13. Miyake S, Makimura M, Kanegae Y, et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA. 1996; 93:1320-1324.
14. Kanegae Y, Lee G, Sato Y, et al. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 1995;23:3816-3821.
15. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-xl, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74:597-608.
16. Shinoura N, Ohashi M, Yoshida Y, et al. Construction, propagation, and titer estimation of recombinant adenoviruses for pro-apoptotic genes. Hum Gene Ther. 1998;9: 2683-2689.
17. Sato N, Wang S, Li L, et al. A novel strategy for introducing exogenous bcl-2 into neuronal cells: the Cre/loxP system-mediated activation of bcl-2 for preventing programmed cell death using recombinant adenoviruses. Mol Cell Neurosci. 1998;12:65-78.
18. Miura M, Tamura T, Aoyama A, et al. The promoter elements of the mouse myelin basic protein gene function efficiently in NG108-15 neuronal/glial cells. Gene. 1989;75: 31-38.
19. Telford WG, King LE, Fraker PJ. Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif. 1991;24:447-459.
20. Tellefson AE, Hermiston TW, Lichtenstein DL, et al. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature. 1998;392:726-730.
21. Tartaglia LA, Ayres TM, Wong GH, et al. A novel domain within the 55-kDa TNF receptor signals cell death. Cell. 1993;74:845-853.
22. Boldin MP, Mett IL, Varfolomeev EE, et al. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO-1 prompts signaling for TNF and Fas/APO-1 effects. J Biol Chem. 1995;270: 387-391.
23. Muzio M, Stockwell BR, Stennicke HR, et al. An induced proximity model for caspase-8 activation. J Biol Chem. 1998;273:2926-2930.
24. Chinnaiyan AM, O'Rourke K, Tewari M, et al. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995;81: 505-512.
25. Mapara MY, Bargou R, Zugck C, et al. APO-1-mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol. 1993;23:702-708.
26. Wallach D, Kovalenko AV, Varfolomeev EE, et al. Death-inducing functions of ligands of the tumor necrosis factor family: a Sanhedrin verdict. Curr Opin Immunol. 1998;10: 279-288.
27. Sato T, Irie S, Kitada S, et al. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science. 1995;268: 411-415.
28. Srinivasula SM, Ahmad M, Ottilie S, et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J Biol Chem. 1997;272: 18542-18545.
29. Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by cellular FLIP. Nature. 1997;388:190-195.
30. Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 1997;387:773-776.
31. Krishna M, Smith TM, Recht LD. Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy. J Neurosurg. 1995;83: 1017-1022.
32. Nakasu S, Nakasu Y, Nioka H, et al. bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol. 1994;88:520-526.
33. Krajewski S, Krajewska M, Ehrmann J, et al. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin. Am J Pathol. 1997;150:805-814.
34. L is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci. 1998;18:1009-1019.
35. L. Am J Pathol. 1996;149:795-803.
36. L gene in human gastric adenomas and carcinomas. Int J Cancer. 1996;68:727-730.
37. L. Blood. 1996;87:3837-3843.
38. Ram Z, Culver KW, Oshiro EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med. 1997;3:1354-1361.
39. Krajewska MK, Wang HG, Krajewski S, et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res. 1997;57:1605-1613.
40. Rensing-Ehl A, Malipiero U, Irmler M, et al. Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway. Eur J Immunol. 1996;26:2271-2274.
41. Micheau O, Solary E, Hammann A, et al. Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity. J Natl Cancer Inst. 1997;89:783-789.
42. Muller M, Strand S, Hug H, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest. 1997;99:403-413.
43. Owen-Schaub LB, Zhang W, Cusack JC, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol. 1995; 15:3041-3048.